Skip to main content
. 2015 Oct 9;9:5569–5578. doi: 10.2147/DDDT.S92467

Figure 1.

Figure 1

Novel dehydroepiandrosterone (DHEA) troches.

Note: Photograph displaying the novel DHEA-containing oral troches designed by our group, cross-scored to enable fractional dosages from 12.5 mg to 50 mg.